Edmond de Rothschild Holding’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Edmond de Rothschild Holding’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-300	Closed	-$15K	–	608
2019 Q1	$15K	Hold	300	–	–	﹤0.01%	559
2018 Q4	$14K	Hold	300	–	–	﹤0.01%	624
2018 Q3	$17K	Hold	300	–	–	﹤0.01%	688
2018 Q2	$15K	Hold	300	–	–	﹤0.01%	698
2018 Q1	$15K	Hold	300	–	–	﹤0.01%	719
2017 Q4	$15K	Hold	300	–	–	﹤0.01%	729
2017 Q3	$16K	Buy	+300	New	+$15.4K	﹤0.01%	745
2017 Q1	–	Sell	-525	Closed	-$24K	–	845
2016 Q4	$24K	Hold	525	–	–	﹤0.01%	712
2016 Q3	$26K	Hold	525	–	–	﹤0.01%	734
2016 Q2	$25K	Hold	525	–	–	﹤0.01%	706
2016 Q1	$24K	Buy	+525	New	+$24.6K	﹤0.01%	702

Other funds holding IHE

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Biegel & Waller Columbia, Maryland $179M AUM 1.6% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Edmond de Rothschild Holding's IHE Position: Q2 2019 in Review

Edmond de Rothschild Holding sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2019, closing a stake of 300 shares — an estimated $15K sold.

Edmond de Rothschild Holding first reported a position in IHE in Q1 2016 and held it in 11 quarters. The position peaked at $26K in Q3 2016. 87 funds tracked by Wall St. Rank hold IHE as of Q2 2019.

Edmond de Rothschild Holding reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2019 after selling out during the quarter.
Edmond de Rothschild Holding sold 300 iShares US Pharmaceuticals ETF shares in Q2 2019, an estimated $15K.
Edmond de Rothschild Holding first reported a position in iShares US Pharmaceuticals ETF in Q1 2016 and held it in 11 quarters.
Edmond de Rothschild Holding's iShares US Pharmaceuticals ETF position peaked at $26K in Q3 2016.
87 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2019.

Based on Edmond de Rothschild Holding's 13F filing for Q2 2019, filed 14 Aug 2019.